The recent study using IEF in neonatal screening for α-thalassemia demonstrated that HbBart's level ≥ 3%, MCV ≤ 95 fl, and MCH ≤ 30 pg yielded 100% sensitivity to identify heterozygous α0-thalassemia.
The recent study using IEF in neonatal screening for α-thalassemia demonstrated that HbBart'slevel ≥ 3%, MCV ≤ 95 fl, and MCH ≤ 30 pg yielded 100% sensitivity to identify heterozygous α0-thalassemia.